withdrawal symptoms mitragynine pseudoindoxyl displayed indication actually enjoyed taking drug early promise nonaddictive majumdar says team reported findings month varadi says results indicate mitragynine pseudoindoxyl peculiar ability activate mu receptor possibly making powerful painkiller reduces addictive potentially deadly effects lower withdrawal tolerance double whammy varadi says kratom compounds clinically studied humans andrew kruegel pharmacologist columbia not involved varadi study says results hold promise better designer painkillers compounds superior codeine oxycodone minimum rid respiratory problems save thousands lives kruegel says tweak properties better natural starting point research able legally continue adds dea plans place kratom psychoactive ingredients agency restricted controlled substance